Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus
Journal of Antimicrobial Chemotherapy · 03.06.2026 · 81 (7)
DOI: 10.1093/jac/dkag186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 03.06.2026. Verfasst von Gen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Australian Infectious Diseases Research Centre, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia. Hauptthemen laut MEDLINE: Enterococcus faecium, Oxyquinoline, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, The University of Queensland Research Training.
Abstract (Originalsprache)
Background and objectives Enterococcus faecium and Staphylococcus aureus are opportunistic bacterial pathogens with a demonstrated capacity to develop antimicrobial resistance and cause serious life-threatening infections, underscoring the urgent need for new therapeutic options.
Methods
Here, we have synthesized and characterized the activities of an 8-hydroxyquinoline–based ionophore antibiotic (ionophoroantibiotic; IP antibiotic), designated ‘IP-antibiotic 12.’ Results Using multidrug-resistant strains of E. faecium and S. aureus, in vitro investigations revealed that IP-antibiotic 12 exhibits bactericidal activity, demonstrates a low propensity for resistance emergence, increases the susceptibility of particular strains to select antibiotics, possesses a favorable toxicity profile, and dysregulates bacterial metal homeostasis. IP-antibiotic 12 demonstrated therapeutic efficacy against multidrug-resistant S. aureus skin infection, as a direct-acting topical antimicrobial and antibiotic adjunct when co-administered with oral linezolid. Interestingly, it was not efficacious in murine models of systemic and pulmonary infection.
Conclusions
These results highlight the potential of IP-antibiotic 12 as a novel therapeutic against multidrug-resistant gram-positive bacteria and provide a foundation for the development of next-generation IP-antibiotics with enhanced in vivo therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian Infectious Diseases Research Centre, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
- Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD 4222, Australia.
- Community for Open Antimicrobial Drug Discovery, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
Förderung
- National Health and Medical Research Council of Australia
- The University of Queensland Research Training
Zitieren
APA
Li, G., El-Deeb, I. M., Whyte, H. G., Blaskovich, M. A. T., Walker, M. J., von Itzstein, M., & De Oliveira, D. M. P. (2026). Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 81(7). https://doi.org/10.1093/jac/dkag186
Vancouver
Li G, El-Deeb IM, Whyte HG, Blaskovich MAT, Walker MJ, von Itzstein M, et al. Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 2026;81(7). doi:10.1093/jac/dkag186
BibTeX
@article{Li2026,
author = {Li, Gen and El-Deeb, Ibrahim M and Whyte, Hayden G and Blaskovich, Mark A T and Walker, Mark J and von Itzstein, Mark and De Oliveira, David M P},
title = {Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {7},
doi = {10.1093/jac/dkag186}
}
EUVIMED